当前位置：
X-MOL 学术
›
J. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma
Journal of Clinical Oncology ( IF 45.3 ) Pub Date : 2023 , DOI: 10.1200/jco.22.02567 Martin F Kaiser 1, 2 , Andrew Hall 3 , Katrina Walker 3 , Amy Sherborne 1 , Ruth M De Tute 4 , Nicola Newnham 5 , Sadie Roberts 3 , Emma Ingleson 3 , Kristian Bowles 6 , Mamta Garg 7 , Anand Lokare 8 , Christina Messiou 1, 2 , Richard S Houlston 1 , Graham Jackson 9 , Gordon Cook 3, 10 , Guy Pratt 5 , Roger G Owen 4 , Mark T Drayson 5 , Sarah R Brown 3 , Matthew W Jenner 11
Journal of Clinical Oncology ( IF 45.3 ) Pub Date : 2023 , DOI: 10.1200/jco.22.02567 Martin F Kaiser 1, 2 , Andrew Hall 3 , Katrina Walker 3 , Amy Sherborne 1 , Ruth M De Tute 4 , Nicola Newnham 5 , Sadie Roberts 3 , Emma Ingleson 3 , Kristian Bowles 6 , Mamta Garg 7 , Anand Lokare 8 , Christina Messiou 1, 2 , Richard S Houlston 1 , Graham Jackson 9 , Gordon Cook 3, 10 , Guy Pratt 5 , Roger G Owen 4 , Mark T Drayson 5 , Sarah R Brown 3 , Matthew W Jenner 11
Affiliation
Journal of Clinical Oncology, Ahead of Print.
中文翻译：
达雷妥尤单抗、环磷酰胺、硼替佐米、来那度胺和地塞米松作为诱导和扩展巩固治疗可改善超高危多发性骨髓瘤的预后
临床肿瘤学杂志，印刷前。
更新日期：2023-06-19
中文翻译：
达雷妥尤单抗、环磷酰胺、硼替佐米、来那度胺和地塞米松作为诱导和扩展巩固治疗可改善超高危多发性骨髓瘤的预后
临床肿瘤学杂志，印刷前。
京公网安备 11010802027423号